Reported value
$11.7B
2026 Q2 filing
| Ticker | Company | Weight | Shares | Change |
|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS INC | 9.14% | 1,993,687 | HELD |
| ARGX | ARGENX SE - ADR | 5.62% | 709,446 | HELD |
| PTCT | PTC THERAPEUTICS, INC. | 5.39% | 7,746,415 | HELD |
| PTGX | Protagonist Therapeutics, Inc | 5.30% | 5,061,175 | HELD |
| CGON | CG ONCOLOGY INC | 5.16% | 8,514,590 | ADDED (+21.9%) |
| INSM | INSMED Inc | 4.41% | 4,842,880 | HELD |
| TNGX | TANGO THERAPEUTICS INC | 3.71% | 13,900,620 | ADDED (+4.5%) |
| SYRE | SPYRE THERAPEUTICS INC | 3.22% | 4,251,996 | ADDED (+1.9%) |
| CELC | Celcuity Inc. | 2.95% | 3,304,903 | ADDED (+8.7%) |
| ERAS | ERASCA INC | 2.81% | 17,946,754 | ADDED (+11.1%) |
| RDNT | RadNet, Inc. | 2.55% | 4,846,958 | ADDED (+13.1%) |
| ORKA | Oruka Therapeutics, Inc. | 2.55% | 3,139,030 | ADDED (+52.5%) |
| NTRA | Natera, Inc. | 2.32% | 1,000,000 | TRIMMED (-20.0%) |
| RARE | Ultragenyx Pharmaceutical Inc. | 2.22% | 7,796,895 | ADDED (+113.7%) |
| IRTC | iRhythm Holdings, Inc. | 2.22% | 2,182,631 | ADDED (+30.8%) |
| CYTK | CYTOKINETICS INC | 2.08% | 2,862,003 | ADDED (+5.2%) |
| KLRA | KAILERA THERAPEUTICS INC | 2.03% | 10,776,820 | NEW |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | 1.95% | 2,655,695 | HELD |
| GH | Guardant Health, Inc. | 1.90% | 1,481,033 | HELD |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.82% | 1,267,925 | ADDED (+19.4%) |
| TARS | TARSUS PHARMACEUTICALS INC | 1.80% | 3,357,059 | ADDED (+0.3%) |
| STOK | STOKE THERAPEUTICS INC | 1.57% | 5,623,525 | HELD |
| QURE | uniQure N.V. | 1.55% | 3,941,572 | ADDED (+52.4%) |
| ACAD | ACADIA PHARMACEUTICALS INC | 1.54% | 7,144,524 | HELD |
| RGEN | REPLIGEN CORP | 1.45% | 1,240,637 | ADDED (+2.9%) |
| URGN | UroGen Pharma Ltd. | 1.43% | 4,543,895 | HELD |
| GHRS | GH Research PLC | 1.36% | 5,933,815 | HELD |
| IMCR | IMMUNOCORE HOLDINGS PLC-ADR | 1.32% | 4,869,798 | HELD |
| CMPS | COMPASS Pathways plc | 1.29% | 10,700,974 | ADDED (+0.6%) |
| IMTX | Immatics N.V. | 1.12% | 12,946,176 | ADDED (+0.6%) |
| ZLAB | Zai Lab Ltd | 1.07% | 6,574,032 | HELD |
| IMVT | Immunovant, Inc. | 1.05% | 3,177,849 | HELD |
| BLTE | BELITE BIO, INC | 0.94% | 715,332 | HELD |
| XNCR | XENCOR INC | 0.93% | 6,777,461 | HELD |
| TSHA | Taysha Gene Therapies, Inc. | 0.79% | 13,560,258 | TRIMMED (-0.9%) |
| COGT | COGENT BIOSCIENCES INC | 0.76% | 2,309,021 | TRIMMED (-57.7%) |
| ALKS | Alkermes plc. | 0.75% | 1,672,356 | HELD |
| GPCR | STRUCTURE THERAPEUTICS INC | 0.74% | 1,607,507 | NEW |
| REPL | REPLIMUNE GROUP INC | 0.70% | 7,411,581 | ADDED (+0.7%) |
| CSTL | CASTLE BIOSCIENCES INC | 0.57% | 2,778,335 | ADDED (+0.7%) |
| CADL | CANDEL THERAPEUTICS INC | 0.56% | 6,422,018 | HELD |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 0.52% | 17,687,772 | HELD |
| KOD | Kodiak Sciences Inc. | 0.49% | 1,487,934 | HELD |
| AKTS | Aktis Oncology, Inc. | 0.44% | 1,592,043 | HELD |
| AXGN | Axogen, Inc. | 0.40% | 1,011,576 | NEW |
| DHR | DANAHER CORP /DE/ | 0.37% | 230,000 | NEW |
| CGEM | Cullinan Therapeutics, Inc. | 0.37% | 2,364,347 | ADDED (+38.6%) |
| NGNE | NEUROGENE INC | 0.37% | 1,362,456 | HELD |
| HNGE | Hinge Health, Inc. | 0.35% | 500,000 | TRIMMED (-74.1%) |
| OBIO | ORCHESTRA BIOMED HOLDINGS IN | 0.35% | 9,556,063 | ADDED (+15.0%) |
| SLDB | SOLID BIOSCIENCES INC | 0.33% | 3,892,926 | NEW |
| SVRA | SAVARA INC | 0.31% | 5,952,380 | HELD |
| AQST | AQUESTIVE THERAPEUTICS INC | 0.26% | 7,426,471 | HELD |
| KYMR | KYMERA THERAPEUTICS INC | 0.23% | 240,000 | HELD |
| VSTM | Verastem, Inc. | 0.22% | 6,635,793 | ADDED (+0.9%) |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 0.21% | 248,063 | HELD |
| BBNX | Beta Bionics, Inc. | 0.20% | 1,500,000 | TRIMMED (-25.0%) |
| IPSC | CENTURY THERAPEUTICS INC | 0.18% | 8,695,652 | HELD |
| EVMN | EVOMMUNE INC | 0.17% | 1,502,235 | HELD |
| BEAM | Beam Therapeutics Inc. | 0.17% | 570,394 | HELD |
| DFTX | DEFINIUM THERAPEUTICS INC | 0.16% | 400,000 | ADDED (+33.3%) |
| IDYA | IDEAYA BIOSCIENCES INC | 0.12% | 370,370 | NEW |
| MIST | MILESTONE PHARMACEUTICALS IN | 0.09% | 7,833,336 | ADDED (+23.7%) |
| OCGN | OCUGEN INC | 0.09% | 6,666,666 | HELD |
| TENX | TENAX THERAPEUTICS INC | 0.09% | 696,570 | ADDED (+88.1%) |
| HTFL | HEARTFLOW INC | 0.07% | 295,000 | TRIMMED (-40.4%) |
| WVE | Wave Life Sciences, Inc. | 0.07% | 1,350,000 | HELD |
| LRMR | LARIMAR THERAPEUTICS INC | 0.07% | 2,565,999 | ADDED (+71.1%) |
| LMRI | LUMEXA IMAGING HOLDINGS INC | 0.06% | 650,000 | HELD |
| ALLO | ALLOGENE THERAPEUTICS INC | 0.06% | 3,250,000 | NEW |
| CBIO | CRESCENT BIOPHARMA, INC. | 0.06% | 372,856 | HELD |
| FDMT | 4D Molecular Therapeutics, Inc. | 0.05% | 475,737 | HELD |
| MAZE | MAZE THERAPEUTICS INC | 0.05% | 212,000 | NEW |
| CAPR | CAPRICOR THERAPEUTICS INC | 0.05% | 250,000 | HELD |
| KLRS | KALARIS THERAPEUTICS INC | 0.05% | 1,300,000 | HELD |
| ABVX | Abivax S.A. | 0.03% | 26,400 | NEW |
| AVTX | AVALO THERAPEUTICS INC | 0.03% | 175,000 | TRIMMED (-79.6%) |
| MDLN | Medline Inc. | 0.02% | 70,000 | HELD |
| IRON | DISC MEDICINE INC | 0.02% | 30,000 | HELD |
| IMA | IMAGENEBIO INC | 0.02% | 334,445 | HELD |
| XGN | EXAGEN INC. | 0.01% | 195,000 | TRIMMED (-50.7%) |
| RCKT | ROCKET PHARMACEUTICALS, INC. | <0.01% | 350,000 | HELD |
Exited this quarter: ARWR, CMPX, FLGT, ISRG, IVA, JBIO, OMDA, SYK, WAY.
Source: SEC Form 13F filing for the quarter ended Jun 30, 2026, filed Aug 14, 2026. CIK 0001493215. Change labels compare with the fund’s previous quarterly filing. 13F filings cover long positions only.
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.